CompoAtlas

Alpha Lipoic Acid

Food supplement declared in France, declaration No 2023-1-1021, decision dated 21 January 2023

Alpha Lipoic Acid (Kobho High Bioavailability) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Kobho High Bioavailability
Food business operator placing the product on the market
Evolvere Science Labs S.L.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
1 capsule
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous antidiabétiques

Declaration 328295, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Other active ingredients

NamePer day
Acide lipoïquenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E460, E464, E470b, E551

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les compléments alimentaires ne doivent pas être utilisés en remplacement d'une alimentation équilibrée et variée et d'un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Déconseillé aux personnes diabétiques, aux femmes enceintes et aux femmes allaitantes. Conserver dans un endroit frais et sec, à l'abri de la lumière.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : Kobho High Bioavailability

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line